Regulation & Compliance

The partnership between Nium and Coinbase creates a multi-rail system, enabling USDC stablecoin payouts and revolutionizing corporate treasury management.

Beyond the lab, a Miami research institute is tackling the city's mental health crisis by embedding itself in the community. But is it just good will?

A new AI-driven platform moves beyond static reports, offering continuous genomic updates to give cancer patients access to the latest treatment options.

AI promises to transform drug discovery, but billions in investment are at risk. A new report reveals why the real bottleneck isn't tech, but data itself.

A 3-year study of COVID survivors reveals a startling new risk: late-onset cognitive impairment, pushing for a radical shift in long-term brain monitoring.

A new AI tool is automating healthcare's most hated paperwork, getting patients on complex drugs in 48 hours and giving doctors back their time.

The medtech giant posts Q1 growth and secures critical EU approvals for new devices, navigating post-pandemic shifts and geopolitical headwinds with strong cash flow.

The digital health firm is tackling rising care complexity by adding musculoskeletal support to its multi-condition platform, aiming to lower costs and improve outcomes.

Nexcess merges Liquid Web and Servers.com, creating a unified cloud ecosystem for high-stakes businesses. What does this mean for the future of hosting?

A new platform uses the MCP open standard to let AI tools like ChatGPT securely analyze sensitive client data, aiming to transform advisor productivity.

Rasa's recognition as a Strong Performer in a key Forrester Wave report highlights a growing enterprise demand for AI with data sovereignty and developer control.

New partnership offers startups access to money market funds and T-bonds, aiming to turn idle cash into a high-yield, liquid asset in a competitive market.

A new liquid biopsy using viral DNA gets FDA fast-track status, promising to detect liver cancer recurrence more than five months earlier than imaging scans.

A UK biotech's Rincell-1 therapy enters human trials, aiming to regenerate auditory nerves and restore hearing where current technology falls short.

UnitedHealth Group posted strong Q1 earnings but is shedding members in a bold pivot, divesting globally to double down on US-based AI and tech innovation.

A novel drug candidate from Addex Therapeutics shows robust cough suppression in key preclinical studies, offering hope for a treatment without current side effects.

The ADGM-regulated firm now connects Tron, Solana, and more to UAE banking, building critical infrastructure for the booming $300 billion stablecoin market.

California's largest water coalition is demanding a fundamental overhaul of the state's water system, setting the stage for a major political battle in 2026.

Australian GRC leader Protecht buys US-based VISO TRUST, integrating advanced AI to automate security and dominate the rapidly expanding risk management market.

As tough new EPA rules on PFAS create a multi-billion dollar market, a major investment in a novel, plant-based filter aims to dominate U.S. water cleanup.